Cortellis powers life sciences innovation with trusted content, analytics and technology.

Learn more about Cortellis

Newport

Trusted by 80% of the world’s Top 50 generic and API and finished dose manufacturers, Newport Premium enables companies of all sizes, business models, strategies and geographic reach to quickly grow their product portfolios, find exclusive API suppliers, penetrate new markets, identify partners and monitor their competition.
Learn more

Cortellis Competitive Intelligence

Trusted by more than 40,000 users worldwide, Cortellis Competitive Intelligence allows you to keep a constant watch on competitors, summarizes and prioritizes the product pipelines in your area of research, monitors new patent filing, and assesses the attractiveness of the companies you are interested in.

Learn more

Cortellis Regulatory Intelligence

Cortellis Regulatory Intelligence is a single reliable source to monitor regulatory changes, understand submission routes and local practices, compare regulatory requirements across countries, and conduct pre- and post-marketing surveillance.

Learn more

Cortellis Clinical Trials Intelligence

Cortellis Clinical Trials Intelligence is a powerful resource to accelerate clinical development decisions, inform portfolio strategy, select trial sites and provide key competitive intelligence. Expertly curated clinical trials information covering all Indications is integrated with other scientific and competitive intelligence from Clarivate Analytics, so you can make the most informed decisions to maximize your clinical investments and reduce risk.

Learn more

Integrity

Integrity enhances your drug discovery and development research by integrating essential biological, chemical and pharmacological data to support successful drug research and development.

Learn more

Other Life Sciences Solutions from Clarivate Analytics

Click here to see more on our other Life Sciences Solutions

Subscribe to the Cortellis Newsletter

Subscribe to our Cortellis newsletter to get the latest news.

Subscribe

A message from our CEO, Jerre Stead, about COVID-19 - Read more.